Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
When orphan drugs are blockbusters: Researchers call on Congress to make companies pay back tax credits
3 years ago
R&D
AstraZeneca blockbuster Farxiga adds new heart indication to label
3 years ago
FDA+
Gilead wins US patent trial over HIV prevention drugs
3 years ago
Law
After warning letters and fatal poisonings, FDA issues guidance for stringent testing of contaminants
3 years ago
FDA+
Manufacturing
Roche, Merck and Pfizer lead US pharma corporate reputation ranking by patient groups
3 years ago
Marketing
Bristol Myers Squibb lays off 48 in New Jersey
3 years ago
People
Abortion providers sue FDA in a Virginia federal court over mifepristone restrictions
3 years ago
MarketingRx roundup: AbbVie debuts Vraylar campaign for depression; Amylyx re-ups “Get Inked” for ALS effort
3 years ago
Marketing
Tarsus issues 'call to action' months before FDA decision on eye mite treatment
3 years ago
Marketing
Updated: EQRx abandons its mission of drug price reform, will cut more than half of employees
3 years ago
R&D
BioPharma Solutions sold for $4B+ to two private equity firms
3 years ago
Deals
Manufacturing
Catalent delays quarterly call as stock takes another dive
3 years ago
Manufacturing
Viatris leans in on brand drug portfolio for future growth
3 years ago
Marketing
'Practically impossible': On the difficulties of introducing new medicines across all 27 EU member states
3 years ago
Law
Amgen and Entera Bio call off oral drug delivery partnership after four years
3 years ago
Deals
Eisai’s cancer drug Halaven at the center of $2B pact with BlissBio, like its Bristol Myers ADC deal
3 years ago
Deals
China
Ginkgo and Boehringer Ingelheim sign pact to mine microbes and find new molecules
3 years ago
Deals
Covid-19 public health emergencies are ending. What's changing?
3 years ago
Coronavirus
How electronic health records evolved from digital tools to marketing strategy
3 years ago
Marketing
Sandoz joins up with B2B pharma to commercialize six biosimilars in the US
3 years ago
Deals
With Eylea in decline, Regeneron awaits FDA approval for higher dose of blockbuster
3 years ago
R&D
FDA hits Novo Nordisk with CRL for its once-daily hemophilia drug concizumab
3 years ago
FDA+
Covid drug and vaccine sales nosedive, denting biopharma revenue across the board
3 years ago
Coronavirus
Novo Nordisk to restrict starter dose supply for weight loss drug Wegovy
3 years ago
First page
Previous page
129
130
131
132
133
134
135
Next page
Last page